Category:

Health

Latest

US SC rejects Johnson & Johnson’s appeal of $2 billion penalty in baby powder cancer case

An investigation found that J&J knew for decades that asbestos, a carcinogen, was present in its talc products. Internal company records, trial testimony and other evidence showed that from at least 1971 to the early 2000s, J&J’s raw talc and finished powders sometimes tested positive for small amounts of asbestos.

The company said in May 2020 it would stop selling its baby powder talc in the United States and Canada, citing changes in consumer habits and what it called “misinformation” about the product’s safety amid numerous legal challenges.

read more

Tobacco consumption is the single leading cause of cancer in India

“Smokers are affected far more with severe Covid complications than non-smokers, so quitting tobacco should be the top most promise that one should make to one self,” said Mudit Agarwal, Sr. Consultant — Head & Neck Surgical Oncology at RGCIRC.

The World Health Organization (WHO) has also stated that tobacco use increases the risk of suffering from serious symptoms due to Covid-19 illness. Smokers have up to a 50 per cent higher risk of developing severe disease and death from Covid-19, WHO has stated.

read more

AM Best maintains negative outlook on India non-life insurance

However, in fiscal year 2021, despite India’s GDP contracting by approximately 8%, the non-life insurance market achieved a positive, albeit muted, growth rate of over 5%. Prospectively, AM Best expects the trajectory of non-life insurance premiums in India to continue to be one of growth over the long term with rising consumer awareness and accessibility of insurance products.
Factors that could lead AM Best to revise its segment outlook to stable from negative include evidence of sustainable improvement in underwriting performance, supported by better pricing discipline, as well as an improved balance of overall earnings and stabilised economic indicators.

read more

Lilly India gets nod for use of monoclonal antibody drugs for treating Covid-19

Lilly said it is engaging in active dialogue with the Indian government and regulatory authorities to donate bamlanivimab and etesevimab in order to speed up access and provide treatment options for patients with Covid-19. The drugs together have been authorised under emergency use authorisation in the United States and select European Union countries for treatment of mild to moderate Covid-19.

read more

X-Ray Setu plans to on-board 10K doctors for COVID detection in rural areas

”We are planning to create a strong network of 10,000 doctors in the next 15 days who are trained in leveraging XraySetu, so that when the third COVID wave comes, we are ready with solutions that can reach doctors in rural areas,” said non-profit organisation Artpark CEO Umakant Soni.

He said that India had 5,335 rural community health centres (CHCs) as of March 31, 2019 that can be used and private estimates indicate that two-third of them have a working X-Ray machine and a technician to operate it.

read more

By July or early August, will have enough COVID-19 vaccine to inoculate 1 cr people a day: Centre

“Mixing of vaccine is not the protocol yet, same vaccines (Covishield and Covaxin) are to be administered for both doses. Stick to the SOP. There’s international research underway on the mixing of vaccines as the possibility of a positive effect is also plausible but a harmful reaction cannot be ruled out either. It is an unresolved scientific question, science will settle it,” said NITI Aayog’s V K Paul at the press briefing.

read more